Ricks C A, Avakian A, Bryan T, Gildersleeve R, Haddad E, Ilich R, King S, Murray L, Phelps P, Poston R, Whitfill C, Williams C
EMBREX, Inc., Research Triangle Park, North Carolina 27709, USA.
Adv Vet Med. 1999;41:495-515.
More than 80% of the U.S. broiler industry has converted to the in ovo vaccination process for control of Marek's disease. Providing certain criteria are met, including timing and site of vaccine placement, vaccine mixing, machine sanitization, and hatchery management specifications, this has proven to be an efficacious and convenient method of vaccination. Efforts to extend the technology for other viral vaccines including Newcastle, bronchitis and bursal disease, and bacterial and parasitic vaccines are in progress. Collectively, these studies demonstrate that in ovo vaccination technology using approved vaccine is a safe, efficacious, and convenient method for vaccination of poultry.
美国超过80%的肉鸡行业已转向采用胚内接种疫苗的方法来控制马立克氏病。只要满足某些标准，包括疫苗接种的时间和部位、疫苗混合、机器消毒以及孵化场管理规范，这种方法已被证明是一种有效且便捷的疫苗接种方式。目前正在努力将该技术扩展用于其他病毒疫苗，包括新城疫、支气管炎和法氏囊病疫苗，以及细菌和寄生虫疫苗。总体而言，这些研究表明，使用经批准疫苗的胚内接种疫苗技术是一种安全、有效且便捷的家禽疫苗接种方法。
